Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies
- PMID: 86990
- PMCID: PMC383264
- DOI: 10.1073/pnas.76.3.1425
Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies
Abstract
Variants of A/PR/8/34 (HON1) influenza virus, having hemagglutinin molecules with probably a single altered antigenic determinant, were isolated by growing the virus in the presence of the monoclonal hybridoma antibody PEG-1. The variants were analyzed by peptide mapping and characterized antigenically by using PEG-1 and four other monoclonal hybridoma antibodies to PR8 hemagglutinin. Peptide maps of the large hemagglutinin polypeptide, HA1, from 8 out of 10 variants showed a single changed peptide. This peptide from two of the variants was analyzed, and in each case a serine residue in the wild-type hemagglutinin was replaced by leucine in the variant. Although these eight variants showed identical peptide maps, one could be discriminated antigenically from the others with one of the hybridomas. (The peptide maps represented about one-third of the HA1 molecule.) Of the other two variants, one gave the same HA1 map as the wild type, but could be distinguished antigenically from wild-type virus by two of the hybridomas. The other was unique, and could be distinguished, both antigenically and by peptide mapping, from the other variants. Since a large number of the variants selected with PEG-1 showed the same peptide change, it is likely that this alteration in amino acid sequence (serine to leucine) was responsible for the inability of the variants to bind PEG-1 monoclonal antibody. We do not know, however, whether the changed amino acids were located within the antigenic sites or whether the change occurred somewhere else in the hemagglutinin molecule and altered the determinants through conformational changes.
Similar articles
-
Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies.J Exp Med. 1978 Aug 1;148(2):383-92. doi: 10.1084/jem.148.2.383. J Exp Med. 1978. PMID: 359746 Free PMC article.
-
The mechanism of antigenic drift in influenza viruses: analysis of Hong Kong (H3N2) variants with monoclonal antibodies to the hemagglutinin molecule.Ann N Y Acad Sci. 1980;354:142-61. doi: 10.1111/j.1749-6632.1980.tb27964.x. Ann N Y Acad Sci. 1980. PMID: 6164328
-
Antigenic structure of the hemagglutinin of influenza virus B/Hong Kong/8/73 as determined from gene sequence analysis of variants selected with monoclonal antibodies.Virology. 1984 Dec;139(2):384-92. doi: 10.1016/0042-6822(84)90384-2. Virology. 1984. PMID: 6083660
-
Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1.Virology. 1986 Dec;155(2):625-32. doi: 10.1016/0042-6822(86)90222-9. Virology. 1986. PMID: 2431541
-
[Protective antigen of influenza virus].Nihon Rinsho. 1997 Oct;55(10):2719-24. Nihon Rinsho. 1997. PMID: 9360397 Review. Japanese.
Cited by
-
Serology and energetics of cross-reactions among the H3 antigens of influenza viruses.Infect Immun. 1980 Feb;27(2):397-404. doi: 10.1128/iai.27.2.397-404.1980. Infect Immun. 1980. PMID: 6155332 Free PMC article.
-
Viral immunodiagnosis.Yale J Biol Med. 1980 Jan-Feb;53(1):71-83. Yale J Biol Med. 1980. PMID: 6990636 Free PMC article. Review.
-
Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms.Clin Vaccine Immunol. 2016 Jun 6;23(6):483-495. doi: 10.1128/CVI.00085-16. Print 2016 Jun. Clin Vaccine Immunol. 2016. PMID: 27074939 Free PMC article.
-
Hemagglutinin mutants of swine influenza virus differing in replication characteristics in their natural host.Infect Immun. 1979 Oct;26(1):197-201. doi: 10.1128/iai.26.1.197-201.1979. Infect Immun. 1979. PMID: 227792 Free PMC article.
-
Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.Viral Immunol. 2018 Mar;31(2):124-132. doi: 10.1089/vim.2017.0144. Epub 2018 Jan 9. Viral Immunol. 2018. PMID: 29315059 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials